Rosuvastatin FP Impurity B
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Rosuvastatin FP Impurity B

● In Stock

Catalogue No.:VE006136
CAS No.:N/A
Mol. Formula:C22H28FN3O6S
Mol. Weight:481.54 g/mol

Additional information on Rosuvastatin FP Impurity B

Parent drug

Rosuvastatin

IUPAC Name

(3R,5S)-5-[(6RS)-8-fluoro-2-(N-methylmethane-sulfonamido)-4-(propan-2-yl)-5,6-dihydro-benzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

CC(C)C1=NC(N(C)S(C)(=O)=O)=NC2=C1C[C@]([C@](O)([H])C[C@@]([H])(O)CC(O)=O)([H])C3=C2C=CC(F)=C3

InChI

InChI=1S/C22H28FN3O6S/c1-11(2)20-17-10-16(18(28)8-13(27)9-19(29)30)15-7-12(23)5-6-14(15)21(17)25-22(24-20)26(3)33(4,31)32/h5-7,11,13,16,18,27-28H,8-10H2,1-4H3,(H,29,30)/t13-,16-,18+/m1/s1

Description

Rosuvastatin FP Impurity B standard is a well-characterized compound that aligns with key regulatory guidelines, including USP, EMA, JP, and BP. It plays a crucial role in analytical method development, method validation (AMV), and quality control (QC) processes, particularly in the manufacturing of Rosuvastatin. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), ensuring reliable and precise analytical outcomes.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url